Showing 109 to 120 of 171 results
BioNTech Restructures, Shifting Focus to mRNA Cancer Therapies
BioNTech, due to reduced Covid-19 vaccine demand, will cut 250-350 jobs in Marburg and up to 150 in Idar-Oberstein, but add 800-1200 positions elsewhere, focusing on mRNA cancer therapies with a goal of market approval by 2026.
BioNTech Restructures, Shifting Focus to mRNA Cancer Therapies
BioNTech, due to reduced Covid-19 vaccine demand, will cut 250-350 jobs in Marburg and up to 150 in Idar-Oberstein, but add 800-1200 positions elsewhere, focusing on mRNA cancer therapies with a goal of market approval by 2026.
Progress
40% Bias Score
Mia Love's Glioblastoma Worsens; Family Focuses on Comfort Care
Former US Representative Mia Love, the first Black Republican woman elected to Congress, is facing a worsening prognosis in her battle with glioblastoma brain cancer; her daughter announced that treatment is no longer effective and the family is prioritizing comfort care.
Mia Love's Glioblastoma Worsens; Family Focuses on Comfort Care
Former US Representative Mia Love, the first Black Republican woman elected to Congress, is facing a worsening prognosis in her battle with glioblastoma brain cancer; her daughter announced that treatment is no longer effective and the family is prioritizing comfort care.
Progress
20% Bias Score
Breast Cancer Treatment: Timely Intervention and Reconstruction's Impact on Patient Outcomes
Two Chinese women's breast cancer journeys highlight the importance of early intervention and breast reconstruction options; Hua Hua's delayed treatment resulted in a more extensive mastectomy and DIEP flap reconstruction, while Ling's later reconstruction greatly improved her well-being.
Breast Cancer Treatment: Timely Intervention and Reconstruction's Impact on Patient Outcomes
Two Chinese women's breast cancer journeys highlight the importance of early intervention and breast reconstruction options; Hua Hua's delayed treatment resulted in a more extensive mastectomy and DIEP flap reconstruction, while Ling's later reconstruction greatly improved her well-being.
Progress
56% Bias Score
Brain Tumor Vaccine Shows Promise in Phase 1 Trial
A Phase 1 clinical trial in Heidelberg and Mannheim demonstrated that a new mutation-specific vaccine targeting IDH1 mutations in diffuse gliomas yielded positive results, with 84% of the 33 participants still alive three years after treatment, and 63% showing tumor stabilization.
Brain Tumor Vaccine Shows Promise in Phase 1 Trial
A Phase 1 clinical trial in Heidelberg and Mannheim demonstrated that a new mutation-specific vaccine targeting IDH1 mutations in diffuse gliomas yielded positive results, with 84% of the 33 participants still alive three years after treatment, and 63% showing tumor stabilization.
Progress
40% Bias Score
Nuclear Fusion to Revolutionize Cancer Scans
Bristol-based Astral Systems developed a new method using nuclear fusion to produce radioisotopes for cancer scans, addressing supply chain issues and potentially revolutionizing cancer diagnosis, with smaller, cheaper plants built near hospitals.
Nuclear Fusion to Revolutionize Cancer Scans
Bristol-based Astral Systems developed a new method using nuclear fusion to produce radioisotopes for cancer scans, addressing supply chain issues and potentially revolutionizing cancer diagnosis, with smaller, cheaper plants built near hospitals.
Progress
60% Bias Score
Exercise Linked to Longer Lifespans for Colon Cancer Patients
A study of nearly 3,000 colon cancer patients found that regular exercise, even 5-6 hours weekly, significantly increased survival rates and reduced cancer recurrence, highlighting the importance of lifestyle choices in improving long-term outcomes.
Exercise Linked to Longer Lifespans for Colon Cancer Patients
A study of nearly 3,000 colon cancer patients found that regular exercise, even 5-6 hours weekly, significantly increased survival rates and reduced cancer recurrence, highlighting the importance of lifestyle choices in improving long-term outcomes.
Progress
24% Bias Score
New Method to Measure PTEN Gene Activity May Advance Treatment of Developmental Disorders and Cancers
Researchers at Tel Aviv University developed a new method to precisely measure the activity of the PTEN gene, crucial for cellular growth, which may advance treatments for multiple developmental disorders and cancers; the study's findings were published in Nature Methods.
New Method to Measure PTEN Gene Activity May Advance Treatment of Developmental Disorders and Cancers
Researchers at Tel Aviv University developed a new method to precisely measure the activity of the PTEN gene, crucial for cellular growth, which may advance treatments for multiple developmental disorders and cancers; the study's findings were published in Nature Methods.
Progress
44% Bias Score
Mia Love's Glioblastoma Worsens; Family Prioritizes Comfort Care
Former US Representative Mia Love, 49, is facing a worsening prognosis in her battle against glioblastoma brain cancer; her daughter announced that the cancer is no longer responding to treatment, and the family is prioritizing comfort care.
Mia Love's Glioblastoma Worsens; Family Prioritizes Comfort Care
Former US Representative Mia Love, 49, is facing a worsening prognosis in her battle against glioblastoma brain cancer; her daughter announced that the cancer is no longer responding to treatment, and the family is prioritizing comfort care.
Progress
4% Bias Score
Delayed Breast Cancer Treatment and the Importance of Patient Autonomy in Reconstruction
Two breast cancer patients, Hua Hua and Ling, highlight the importance of timely medical intervention and patient autonomy in breast cancer treatment; Hua Hua's delayed treatment led to advanced-stage cancer and extensive surgery, while Ling's later reconstruction improved her quality of life.
Delayed Breast Cancer Treatment and the Importance of Patient Autonomy in Reconstruction
Two breast cancer patients, Hua Hua and Ling, highlight the importance of timely medical intervention and patient autonomy in breast cancer treatment; Hua Hua's delayed treatment led to advanced-stage cancer and extensive surgery, while Ling's later reconstruction improved her quality of life.
Progress
72% Bias Score
Cancer Cells Cooperate to Acquire Nutrients, Opening New Treatment Avenues
US and French scientists discovered that cancer cells cooperate to obtain nutrients by secreting an enzyme that breaks down oligopeptides into amino acids, creating a shared pool; blocking this enzyme with Bestatin or CRISPR significantly slows tumor growth, suggesting a novel treatment approach.
Cancer Cells Cooperate to Acquire Nutrients, Opening New Treatment Avenues
US and French scientists discovered that cancer cells cooperate to obtain nutrients by secreting an enzyme that breaks down oligopeptides into amino acids, creating a shared pool; blocking this enzyme with Bestatin or CRISPR significantly slows tumor growth, suggesting a novel treatment approach.
Progress
20% Bias Score
Exercise Linked to Longer Lifespans for Colon Cancer Patients
A study of nearly 3,000 colon cancer patients found that regular exercise, such as five to six hours of brisk walking weekly, is associated with longer lifespans and a reduced risk of cancer recurrence, offering hope for improved outcomes and potentially extending lifespans to match those without ca...
Exercise Linked to Longer Lifespans for Colon Cancer Patients
A study of nearly 3,000 colon cancer patients found that regular exercise, such as five to six hours of brisk walking weekly, is associated with longer lifespans and a reduced risk of cancer recurrence, offering hope for improved outcomes and potentially extending lifespans to match those without ca...
Progress
40% Bias Score
Wales Cancer Surgery Program: Funding Success and Uncertain Future
A two-year program in Wales providing a novel cancer surgery has enabled over 40 patients with advanced bowel cancer to receive treatment, resulting in at least one patient being declared cancer-free; however, funding for the program expires in May 2023, prompting calls for permanent funding.
Wales Cancer Surgery Program: Funding Success and Uncertain Future
A two-year program in Wales providing a novel cancer surgery has enabled over 40 patients with advanced bowel cancer to receive treatment, resulting in at least one patient being declared cancer-free; however, funding for the program expires in May 2023, prompting calls for permanent funding.
Progress
44% Bias Score
Showing 109 to 120 of 171 results